The Health Effects of Small-sided Team Handball

January 27, 2020 updated by: Arne Astrup, University of Copenhagen

The Physiological Health Effects of 12 Weeks of Small-sided Team Handball Training in Young Adult Women and Men

The purpose of the project was to examine the fitness and health effects of participation in recreational Team Handball for untrained 20-30 year old healthy men and women.

Study Overview

Status

Completed

Conditions

Detailed Description

Fitness and health effects of 12 weeks of recreational team handball in untrained adult men and women aged 20-30 years"

Adult men and women aged 20-30 years will be recruited to take part in a 12-week intervention with recreational team handball. Half of the participants are men (n=32), who are randomly assigned to a group playing recreational team handball (n=16) and an inactive control group (n=16). The women (n=40) are also divided and assigned to a group with regular participation in recreational team handball (n=20) and an inactive control group (n=20). The training sessions will be offered 2-3 times weekly for 70 minutes per session by a supervised trainer. The sessions involves an injury preventive warm-up and ball exercises for 15 minutes followed by recreational handball on small pitches such as 4 vs 4. A comprehensive testing protocol is conducted before and after the training period. The measurements includes body composition and bone mineralization, blood pressure, resting heart rate, fasting blood sugar, insulin, cholesterol and bone markers. In addition, a number of physical tests which involves fitness level (VO2max), intermittent work, muscle strength and balance will further be conducted. The testing takes place at the University of Copenhagen. The training sessions will also take place at the University of Copenhagen or in a handball club near the University. The study will be approved by the local ethical committee of Copenhagen.

Study Type

Interventional

Enrollment (Actual)

72

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 30 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Healthy women and men from 20-30 years old
  • If women, a regular menstrual cycle length (25 to 32 days) with or without use of contraceptives.

Exclusion Criteria:

  • Known familiar diseases
  • If been smoking for the last two years before recruitment
  • If involved in any regular physical training two years before recruitment
  • Women: a peak oxygen uptake (VO2peak) higher than 45 mL/min/kg
  • Men: a peak oxygen uptake (VO2peak) higher than 51 mL/min/kg

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Active group of men

4 groups are randomized for 12 weeks of intervention; 2 groups are active, 2 groups are inactive:

*1 group of men playing recreational handball

Experimental: Active group of women

4 groups are randomized for 12 weeks of intervention; 2 groups are active, 2 groups are inactive:

*1 group of women playing recreational handball

Experimental: Inactive group of men

4 groups are randomized for 12 weeks of intervention; 2 groups are active, 2 groups are inactive:

*1 group of men continuing their normal lifestyle patterns

Experimental: Inactive group of women

4 groups are randomized for 12 weeks of intervention; 2 groups are active, 2 groups are inactive:

*1 group of women continuing their normal lifestyle patterns

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
VO2max - change is being assessed after 12 weeks of intervention
Time Frame: Measured before and after 12 weeks of intervention
VO2max (mL/kg/min) is a measure of the cardiorespiratory during a treadmill test
Measured before and after 12 weeks of intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fat percentage - change is being assessed after 12 weeks of intervention
Time Frame: Measured before and after 12 weeks of intervention
Measure of fat percentage (%) performed by a dual energy x-ray absorptiometry (DXA scan)
Measured before and after 12 weeks of intervention
Muscle mass - change is being assessed after 12 weeks of intervention
Time Frame: Measured before and after 12 weeks of intervention
Measure of muscle mass (kg) performed by a DXA scan
Measured before and after 12 weeks of intervention
Mineral bone density - change is being assessed after 12 weeks of intervention
Time Frame: Measured before and after 12 weeks of intervention
Mineral bone density (g/cm2) performed by a DXA scan
Measured before and after 12 weeks of intervention
Bone mass - change is being assessed after 12 weeks of intervention
Time Frame: Measured before and after 12 weeks of intervention
Bone mass (kg) performed by a DXA scan
Measured before and after 12 weeks of intervention

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Strength: Isokinetic Maximal voluntary contraction (MVC) - change is being assessed after 12 weeks of intervention
Time Frame: Measured before and after 12 weeks of intervention
Isokinetic MVC (Nm) performed in a isokinetic dynamometer
Measured before and after 12 weeks of intervention
Strength: Isometric MVC - change is being assessed after 12 weeks of intervention
Time Frame: Measured before and after 12 weeks of intervention
Isometric MVC (Nm) performed in a isokinetic dynamometer
Measured before and after 12 weeks of intervention
Strength: Countermovement maximal jumps (CMJ) jump height - change is being assessed after 12 weeks of intervention
Time Frame: Measured before and after 12 weeks of intervention
CMJ jump height (cm) performed on a force plate
Measured before and after 12 weeks of intervention
Strength: CMJ jump height - change is being assessed after 12 weeks of intervention
Time Frame: Measured before and after 12 weeks of intervention
CMJ peak (W/kg) performed on a force plate
Measured before and after 12 weeks of intervention
Postural balance: Sway area - change is being assessed after 12 weeks of intervention
Time Frame: Measured before and after 12 weeks of intervention
Sway area (cm2) performed on a force plate
Measured before and after 12 weeks of intervention
Postural balance: Sway length - change is being assessed after 12 weeks of intervention
Time Frame: Measured before and after 12 weeks of intervention
Sway length (mm) performed on a force plate
Measured before and after 12 weeks of intervention
Citrate synthase (CS) activity - change is being assessed after 12 weeks of intervention
Time Frame: Measured before and after 12 weeks of intervention
Muscle biopsies were taken from the male subjects and analyzed for CS activity (ug/l)
Measured before and after 12 weeks of intervention
3-hydroxyacyl-coenzyme A (CoA) dehydrogenase (HAD) activity - change is being assessed after 12 weeks of intervention
Time Frame: Measured before and after 12 weeks of intervention
Muscle biopsies were taken from the male subjects and analyzed for HAD activity (ug/l)
Measured before and after 12 weeks of intervention
Specific fibre type cross sectional area (CSA) - change is being assessed after 12 weeks of intervention
Time Frame: Measured before and after 12 weeks of intervention
Muscle biopsies were taken from the male subjects and analyzed for specific fibre type CSA (μm2)
Measured before and after 12 weeks of intervention
Fiber type composition - change is being assessed after 12 weeks of intervention
Time Frame: Measured before and after 12 weeks of intervention
Muscle biopsies were taken from the male subjects and analyzed for fibre type composition (%)
Measured before and after 12 weeks of intervention
Capillaries (cap./fiber) - change is being assessed after 12 weeks of intervention
Time Frame: Measured before and after 12 weeks of intervention
Muscle biopsies were taken from the male subjects and analyzed for cap./fibre
Measured before and after 12 weeks of intervention
Capillaries (cap./mm2) - change is being assessed after 12 weeks of intervention
Time Frame: Measured before and after 12 weeks of intervention
Muscle biopsies were taken from the male subjects and analyzed for cap./mm2
Measured before and after 12 weeks of intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2015

Primary Completion (Actual)

July 1, 2016

Study Completion (Actual)

July 1, 2016

Study Registration Dates

First Submitted

January 20, 2020

First Submitted That Met QC Criteria

January 27, 2020

First Posted (Actual)

January 30, 2020

Study Record Updates

Last Update Posted (Actual)

January 30, 2020

Last Update Submitted That Met QC Criteria

January 27, 2020

Last Verified

January 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • H-15008361

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on Control

Subscribe